West Pharmaceutical Services Shares Outstanding 2010-2024 | WST

West Pharmaceutical Services shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • West Pharmaceutical Services shares outstanding for the quarter ending September 30, 2024 were 0.073B, a 2.52% decline year-over-year.
  • West Pharmaceutical Services 2023 shares outstanding were 0.075B, a 0.66% decline from 2022.
  • West Pharmaceutical Services 2022 shares outstanding were 0.076B, a 0.66% decline from 2021.
  • West Pharmaceutical Services 2021 shares outstanding were 0.076B, a 0.66% increase from 2020.
West Pharmaceutical Services Annual Shares Outstanding
(Millions of Shares)
2023 75
2022 76
2021 76
2020 76
2019 75
2018 75
2017 76
2016 75
2015 74
2014 73
2013 71
2012 72
2011 74
2010 73
2009 73
West Pharmaceutical Services Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 73
2024-06-30 74
2024-03-31 74
2023-12-31 75
2023-09-30 75
2023-06-30 75
2023-03-31 76
2022-12-31 76
2022-09-30 76
2022-06-30 76
2022-03-31 76
2021-12-31 76
2021-09-30 76
2021-06-30 76
2021-03-31 76
2020-12-31 76
2020-09-30 76
2020-06-30 76
2020-03-31 76
2019-12-31 75
2019-09-30 76
2019-06-30 75
2019-03-31 75
2018-12-31 75
2018-09-30 76
2018-06-30 75
2018-03-31 76
2017-12-31 76
2017-09-30 76
2017-06-30 76
2017-03-31 75
2016-12-31 75
2016-09-30 75
2016-06-30 75
2016-03-31 74
2015-12-31 74
2015-09-30 74
2015-06-30 74
2015-03-31 73
2014-12-31 73
2014-09-30 73
2014-06-30 72
2014-03-31 72
2013-12-31 71
2013-09-30 71
2013-06-30 71
2013-03-31 70
2012-12-31 72
2012-09-30 69
2012-06-30 73
2012-03-31 74
2011-12-31 74
2011-09-30 74
2011-06-30 74
2011-03-31 74
2010-12-31 73
2010-09-30 73
2010-06-30 73
2010-03-31 73
2009-12-31 73
2009-09-30 73
2009-06-30 72
2009-03-31 72
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36